Health Trials

About this trial

The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension.

Participants will:

Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.

Eligibility criteria

Qualifiers

Men and women 18 years of age or older

Electronic Health Record (EHR) of hypertension AND prescribed at least one BP lowering medication

Office systolic BP of 130 mmHg or higher

Willing and able to comply with the study instructions AND attend a scheduled study visit

Disqualifiers

Women who are pregnant, plan to become pregnant, or are breast-feeding

Know heart failure with reduced ejection fraction and a left ventricular ejection fraction of less than 40%

End-stage kidney disease currently undergoing renal replacement therapy, or an eGFR < 15ml/min/1.73m2

In the opinion of the investigator, any other condition that will preclude participation in the study

Trial design

Treatments tested in this trial

  • Standard medical treatment
  • Clinical Decision Support Tool

Treatment groups

168 Participants
are divided into 2 treatment groups

Locations

1
Cleveland Clinic44195, ClevelandOhio, United States

Sponsors and collaborators

The Cleveland Clinic

Lead sponsor

Source ClinicalTrials.gov